Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02277509 · ClinicalTrials.gov registry record · NA
Chinese Diabetes Prevention Program (Chinese DPP)
A NA study, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02277509 is a NA study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 60 participants.
The verdict
NCT02277509, a NA study, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study is being conducted in two phases. The first phase was a pilot implementation of the study protocol, which provided preliminary data from seeking funding for a larger scale trial. The study focused on testing the effects of a Diabetes Prevention Program (DPP) that has been adapted culturally and linguistically to address diabetes prevention among Chinese immigrants. Study implementation involves a variety capacity building community partnership initiatives. Partnering organizations within New York City (NYC) have included the Chinese Community Partnership for Health (CCPH) of New York Presbyterian Hospital of Lower Manhattan Hospital, the Chinese American Independent Practice Association (CAIPA), the Diabetes Research and Training Center of Albert Einstein College of Medicine (Einstein), and the City University of New York (CUNY) School of Public Health. More recently, our collaboration has expanded the potential for wider dissemination in collaboration with the Pace University Confucius Center of the Confucius Institute. By supporting Chinese language and cultural programs, the Confucius Institute facilitates communication with the 2 billion native Chinese speakers as migration and trade increase interactions globally.
Interventions
- BEHAVIORAL Chinese DPP
- BEHAVIORAL Minimal Intervention Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-04 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02277509
The ClinicalTrials.gov registry entry for NCT02277509 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Chinese DPP is the first listed.
NCT02277509 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02277509 about?
NCT02277509 is a clinical study titled "Chinese Diabetes Prevention Program (Chinese DPP)". This study is being conducted in two phases. The first phase was a pilot implementation of the study protocol, which provided preliminary data from seeking funding for a larger scale trial. The study focused on testing the effects of a Diabetes Prevention Program (DPP) that has been adapted cultural...
What is the current status of trial NCT02277509?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2012-04. Estimated completion is 2014-12.
What interventions are being tested in trial NCT02277509?
The interventions under investigation include: Chinese DPP (BEHAVIORAL), Minimal Intervention Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT02277509?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.